Breast and prostate cancer are among the most diagnosed cancers in women and men and are a significant health burden globally. Although advances in early detection of these diseases have improved survival rates, there are still no effective treatments once they progress to an aggressive disease where they spread (or metastasise) to other parts of the body. In order to find more optimal treatments, we need a better understanding of what causes a tumour cell to gain aggressive properties and become resistant to current therapies.
My vision over the next five years is to use the latest technological advances in gene sequencing to identify factors which predispose breast and prostate cancer cells to become more aggressive and resistant to treatment.
My research aims to:
- Discover new strategies to treat therapy-resistant, metastatic prostate cancer
- Identify factors that cause specific breast cancer cells to gain aggressive properties.
My research will lead to new strategies to detect and treat cancers cells before they become aggressive and spread. This will ultimately lead to earlier diagnosis of cancers most likely to spread, as well as more effective treatments for advanced breast and prostate cancer.